# |
PMID |
Sentence |
1 |
2147681
|
On day 21, all rats received an intravenous injection of 3H-proline, as a radioprecursor of procollagen in bone, dentine and periodontal ligament (PDL) or of amelogenin in enamel; perfusion fixation with an aldehyde mixture was carried out at 20 minutes and 4 hours after isotope injection.
|
2 |
19374040
|
The use of amelogenin protein in the treatment of hard-to-heal wounds.
|
3 |
19374040
|
The use of amelogenin (Xelma, Mölnlycke Health Care) for the treatment of a variety of chronic wounds has been assessed in both case studies and larger clinical trials with encouraging findings.
|
4 |
19374040
|
This article examines the findings of studies relating to amelogenin in the treatment of hard-to-heal wounds.
|
5 |
19374040
|
The use of amelogenin protein in the treatment of hard-to-heal wounds.
|
6 |
19374040
|
The use of amelogenin (Xelma, Mölnlycke Health Care) for the treatment of a variety of chronic wounds has been assessed in both case studies and larger clinical trials with encouraging findings.
|
7 |
19374040
|
This article examines the findings of studies relating to amelogenin in the treatment of hard-to-heal wounds.
|
8 |
19374040
|
The use of amelogenin protein in the treatment of hard-to-heal wounds.
|
9 |
19374040
|
The use of amelogenin (Xelma, Mölnlycke Health Care) for the treatment of a variety of chronic wounds has been assessed in both case studies and larger clinical trials with encouraging findings.
|
10 |
19374040
|
This article examines the findings of studies relating to amelogenin in the treatment of hard-to-heal wounds.
|